New MRI technique could spot dangerous drug interactions early
NCT ID NCT07541807
First seen Apr 24, 2026 · Last updated May 15, 2026 · Updated 7 times
Summary
This study tested a new MRI technique to see how two common drugs, metformin and ciclosporin, affect the liver's ability to process a special dye. Twelve healthy adults each had two MRI scans, with and without the drugs, to measure changes in liver function. The goal was to validate this imaging method as a safe tool for detecting drug-drug interactions early in development.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LIVER DYSFUNCTION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Royal Hallamshire Hospital
Sheffield, United Kingdom
-
University of Sheffield, POLARIS, 18 Claremont Crescent
Sheffield, S10 2RX, United Kingdom
Conditions
Explore the condition pages connected to this study.